D-0348-2022 Class II Terminated

Recalled by Perrigo Company PLC — Allegan, MI

FDA drug recall D-0348-2022 was initiated by Perrigo Company PLC on Jul 27, 2021 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing. The recall status is terminated (terminated Nov 8, 2022). Affected quantity: 44,688 containers.

Recall details

Product Type
Drugs
Report Date
Jan 12, 2022
Initiation Date
Jul 27, 2021
Termination Date
Nov 8, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
44,688 containers

Product description

Rite Aid ALLERGY RELIEF Fexofenadine Hydrochloride tablets, 24HR, 180mg Antihistamine, packaged as a) 30 count bottle, NDC 11822-0571-2 UPC 0 11822 99908 3; b) 150 count bottle, NDC 11822-0571-5 UPC 0 11822 85411 5; Made in the Czech Republic, Distributed by Rite Aid 30 Hunter Lane Camp Hill PA 17011

Reason for recall

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Distribution pattern

Nationwide in the USA

Code information

Lot # a) 1BR0462, Exp 10/31/2022 b) 0GR0528, Exp 3/31/2022; 0KR0473, Exp 4/30/2022; 0LR0369, Exp 6/30/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0348-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0348-2022. Report a data issue: hello@regdatalab.com.